Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Yasuhiro Tsume, Ph.D.
Principal Scientist
Merck & Co., Inc.
Poster(s):
(W1130-02-10) The Advantage and Disadvantage of In Vivo Predictive Dissolution Profiles of BCS Class II Drugs Generated by a Transfer Method and Compendial Method with Different Buffer Species
Wednesday, October 23, 2024
11:30 AM – 12:30 PM
MT
